Krystal Biotech buy Citigroup Inc.
Start price
06.01.26
/
50%
€216.00
Target price
06.01.27
-
Performance (%)
10.28%
Price
23.01.26
€238.20
Summary
This prediction is currently active. The prediction currently has a performance of 10.28%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | -3.013% |
| iShares Core DAX® | -1.764% |
| iShares Nasdaq 100 | -1.632% |
| iShares Nikkei 225® | -2.451% |
| iShares S&P 500 | -2.252% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
